MAIN STUDY: Low Glycaemic Index (GI) Diet in the Management of GDM SUB-STUDY: The Breast Milk Sub-Study
GIinGDM
The Effect of a Low GI Diet on Maternal and Neonatal Markers of Glycaemic Control and Postpartum Diabetes Risk SUBSTUDY The Effect of a Low GI Diet on Postpartum Markers of Oxidation in Breast Milk of Women With Gestational Hyperglycaemia
1 other identifier
interventional
99
1 country
4
Brief Summary
MAIN STUDY: Low glycaemic index (GI) diets are recommended by the Canadian Diabetes Association for treating type 1 and 2 diabetes mellitus (DM), but the role of GI in the management of gestational diabetes(GDM)is not yet clear. The main purpose of this study is to determine the effect of a low GI diet on blood sugar control in women with GDM. The effect of a low GI diet on maternal oxidative stress, pregnancy and delivery outcomes and markers of risk for diabetes after birth in both the mother and baby will also be assessed. SUB-STUDY: The main purpose of the sub-study is to determine if the breast milk (BM) of women with GDM consuming a low GI diet will have a higher antioxidant capacity than the BM of women receiving a medium-high GI diet (control/standard care). The effect of a low glycaemic index diet on maternal dietary intake of specific nutrient-antioxidants (i.e. vitamin C, E, and beta-carotene) (prenatal and postpartum) and concentration of vitamin C, E, and beta-carotene in participants' transitional and mature BM will also be assessed. The ORAC (Oxygen radical absorbance capacity) assay will be used to assess overall antioxidant capacity. The antioxidant capacity of BM in women with GDM will also be compared with that of women without GDM. Hypotheses: MAIN: The use of low-GI foods in the management of GDM reduces postprandial BG and oxidative stress; thereby reducing maternal and infant perinatal complications. SUB-STUDY: Breast milk (BM) of women with GDM consuming a low GI diet will have higher BM antioxidant than women receiving the medium to high GI diet. BM of women with GDM will have lower antioxidant capacity than that of women without GDM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Oct 2011
Typical duration for phase_2
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 19, 2012
CompletedFirst Posted
Study publicly available on registry
May 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedMay 20, 2016
May 1, 2016
3.9 years
April 19, 2012
May 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
MAIN STUDY: Percentage of postprandial self monitored blood glucose (SMBG) values within the target range
SMBG values are obtained 4 times daily (1 fasting and 3 postprandial) throughout the study from the randomization to delivery. The endpoint is a single value for each participant - namely the percentage of all the postprandial SMBG values within the target range recommended by the Canadian Diabetes Association (5.0 to 6.6 mmol/L)
From randomization to delivery
SUB-STUDY (n=75): Oxygen Radical Absorbance Capacity (ORAC) (Antioxidant Capacity) of transitional and mature breast milk.
Breast milk samples (25 mL) will be collected 1 week and 8 weeks after birth from a complete breast milk collection. Measures will be compared between and within groups.
1 week and 8 weeks postpartum
Secondary Outcomes (51)
MAIN STUDY: Infant birth weight
At delivery
MAIN STUDY: Percentage of self-monitored fasting glucose values within the target range
From randomization to delivery
MAIN STUDY: Glucose variability
From randomization to delivery
MAIN STUDY: Insulin prescription incidence
From randomization to delivery
MAIN STUDY: Mean fasting glucose
From randomization to delivery
- +46 more secondary outcomes
Study Arms (2)
Standard Care
PLACEBO COMPARATORStandard care dietary advice to emphasize high fiber foods with a moderate to high GI
Low GI Diet
EXPERIMENTALLow GI dietary advice in addition to standard care
Interventions
Standard dietary advice for women with GDM with special emphasis on use of high fiber or whole grain carbohydrate foods with a medium to high GI. What's on Your Plate? and 3-dimensional food models will be used to teach servings size and meal planning. This groups will be provided with food substitution lists (key-foods method) composed of medium to high GI foods.
Nutrition education according to standard care similar to the control group with supplementary GI-education. GI-education will be taught using the "Stop-Light-Method". This groups will be provided with food substitution lists (key-foods method) composed of low-GI carbohydrate-containing food. The GI-education tool(s) will build on standard care education where patients are taught which food groups contain carbohydrate.
Eligibility Criteria
You may qualify if:
- Women:
- ≥ 18 years of age
- diagnosed with gestational diabetes mellitus (GDM) or impaired glucose tolerance of pregnancy (IGTP) according to Canadian Diabetes Association (CDA) criteria
- being followed within DIP (one of 4 sites)
- willing and able to give informed consent
- willing and able to comply with the study protocol
You may not qualify if:
- Women:
- with acute or chronic illness other than GDM or IGTP or use of drug (other than insulin) which may affect carbohydrate metabolism, gastrointestinal function or carbohydrate digestion (i.e. crohn's disease, HIV/AIDS, liver disease, kidney disease etc.).
- known to have type 1 or type 2 DM prior to pregnancy
- known multi-fetal pregnancy at enrolment
- ≥ 33 weeks' gestation
- prescribed oral anti-hyperglycaemic medication
- insurmountable language barriers
- SUB-STUDY control group (women without GDM) Same as for Main study except absence of GDM
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Torontolead
- Canadian Diabetes Associationcollaborator
- Canadian Institutes of Health Research (CIHR)collaborator
- Canadian Foundation for Dietetic Research (CFDR)collaborator
Study Sites (4)
MAIN STUDY ONLY: St Joseph's Heathcare Hamilton, 50 Charlton Avenue East
Hamilton, Ontario, L8N 4A6, Canada
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
Mt Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Room H145, 2075 Bayview Avenue, Canada
Related Publications (7)
Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med. 1997 Aug;14 Suppl 3:S45-9. doi: 10.1002/(sici)1096-9136(199708)14:3+3.3.co;2-i.
PMID: 9272613BACKGROUNDCeriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med. 1998 Mar;15(3):188-93. doi: 10.1002/(SICI)1096-9136(199803)15:33.0.CO;2-V. No abstract available.
PMID: 9545118BACKGROUNDHuang D, Ou B, Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem. 2005 Mar 23;53(6):1841-56. doi: 10.1021/jf030723c.
PMID: 15769103BACKGROUNDSaenz AT, Elisia I, Innis SM, Friel JK, and Kitts DD. Use of ORAC to assess antioxidant capacity of human milk. Journal of Food Composition and Analysis 22:694-698, 2009
BACKGROUNDElisia I, Kitts DD. Quantification of hexanal as an index of lipid oxidation in human milk and association with antioxidant components. J Clin Biochem Nutr. 2011 Nov;49(3):147-52. doi: 10.3164/jcbn.10-142. Epub 2011 Sep 3.
PMID: 22128211BACKGROUNDWolever, TMS. The Glycaemic Index: A Physiological Classification of Dietary Carbohydrate. Ontario, Canada: CABI, 2006.
BACKGROUNDGrant SM, Wolever TMS. Perceived barriers to application of glycaemic index: valid concerns or lost in translation? Nutrients. 2011 Mar;3(3):330-340. doi: 10.3390/nu3030330. Epub 2011 Feb 28.
PMID: 22254100BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas MS Wolever, MD, PhD
University of Toronto/ St Michael's Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 19, 2012
First Posted
May 2, 2012
Study Start
October 1, 2011
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
May 20, 2016
Record last verified: 2016-05